EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.22.59 | Adenocarcinoma |
20437871 |
Expression analysis of caspase-6, caspase-9 and BNIP3 in prostate cancer. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 4 0 |
3.4.22.59 | Adenoma, Pleomorphic |
27981346 |
Altered expression of apoptosis-regulating miRNAs in salivary gland tumors suggests their involvement in salivary gland tumorigenesis. |
diagnostic usage ongoing research unassigned |
3 1 0 |
3.4.22.59 | Alzheimer Disease |
10438520 |
Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. |
causal interaction ongoing research unassigned |
1 2 0 |
3.4.22.59 | Alzheimer Disease |
11069945 |
Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. |
causal interaction unassigned |
3 0 |
3.4.22.59 | Alzheimer Disease |
15277226 |
Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. |
causal interaction ongoing research therapeutic application unassigned |
4 2 1 0 |
3.4.22.59 | Alzheimer Disease |
15356202 |
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. |
causal interaction therapeutic application unassigned |
4 1 0 |
3.4.22.59 | Alzheimer Disease |
16123779 |
Caspase-1 activation of caspase-6 in human apoptotic neurons. |
ongoing research unassigned |
2 0 |
3.4.22.59 | Alzheimer Disease |
17392160 |
Activation of caspase-6 in aging and mild cognitive impairment. |
causal interaction therapeutic application unassigned |
1 1 0 |
3.4.22.59 | Alzheimer Disease |
18487604 |
Targets of caspase-6 activity in human neurons and Alzheimer disease. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 2 4 1 |
3.4.22.59 | Alzheimer Disease |
19133298 |
Self-activation of Caspase-6 in vitro and in vivo: Caspase-6 activation does not induce cell death in HEK293T cells. |
unassigned |
0 |